Impaired neurotransmission in a mouse model of the slow channel congenital myasthenic syndrome is improved by the sympathomimetic drug ephedrine

Impaired neurotransmission in a mouse model of the slow channel congenital myasthenic syndrome is improved by the sympathomimetic drug ephedrine

Bibliographic Details
Main Authors:	Webster, R, Cossins, J, Lashley, D, Maxwell, S, Beeson, D
Format:	Conference item
Published:	2011

Similar Items

A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment.
by: Webster, R, et al.
Published: (2013)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
by: Lashley, D, et al.
Published: (2010)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
by: Lashley, D, et al.
Published: (2009)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
by: Beeson, D, et al.
Published: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
by: Beeson, D, et al.
Published: (2008)

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
by: Finlayson, S, et al.
Published: (2013)

Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms
by: Cossins, J, et al.
Published: (2010)

EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
by: Lashley, D, et al.
Published: (2009)

Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes.
by: Croxen, R, et al.
Published: (2002)

Allele-specific RNA interference to target a model of slow-channel congenital myasthenic syndrome
by: McClorey, G, et al.
Published: (2008)

The congenital myasthenic syndromes.
by: Palace, J, et al.
Published: (2008)

Effects of epsilon L78P, an acetylcholine receptor mutation that causes slow channel congenital myasthenic syndrome.
by: Shelley, C, et al.
Published: (2003)

A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductance.
by: Webster, R, et al.
Published: (2012)

A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductance
by: Webster, R, et al.
Published: (2012)

Congenital myasthenic syndromes.
by: Beeson, D, et al.
Published: (1997)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
by: Cossins, J, et al.
Published: (2012)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
by: Man, S, et al.
Published: (2005)

CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
by: Müller, J, et al.
Published: (2006)

Congenital myasthenic syndromes: recent advances
by: Beeson, D
Published: (2016)

Synaptic dysfunction in congenital myasthenic syndromes.
by: Beeson, D
Published: (2012)

Congenital myasthenic syndromes: an update.
by: Finlayson, S, et al.
Published: (2013)

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
by: Belaya, K, et al.
Published: (2012)

Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR
by: Zoltowska, K, et al.
Published: (2013)

Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR.
by: Zoltowska, K, et al.
Published: (2013)

Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome.
by: Webster, R, et al.
Published: (2004)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
by: Beeson, D
Published: (2008)

Congenital myasthenic syndrome patients due to AChR epsilon subunit mutations
by: Bonifati, D, et al.
Published: (2004)

Congenital myasthenic syndromes and the neuromuscular junction.
by: Cruz, P, et al.
Published: (2014)

Therapeutic strategies for congenital myasthenic syndromes
by: Lee, M, et al.
Published: (2018)

Novel mutation in the muscle acetylcholine receptor a-subunit underlies a fast channel congenital myasthenic syndrome
by: Webster, R, et al.
Published: (2002)

Fast-channel congenital myasthenic syndrome with a novel acetylcholine receptor mutation at the α-ε subunit interface
by: Webster, R, et al.
Published: (2014)

Fast-channel congenital myasthenic syndrome with a novel acetylcholine receptor mutation at the α-ε subunit interface.
by: Webster, R, et al.
Published: (2014)

The defect in a slow channel myasthenic syndrome mutant, epsilon L221F
by: Hatton, C, et al.
Published: (2000)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
by: Finlayson, S, et al.
Published: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
by: Finlayson, S, et al.
Published: (2013)

Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes (Retracted Article. See vol 72, pg 294, 2009)
by: Croxen, R, et al.
Published: (2002)

Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates
by: Belaya, K, et al.
Published: (2012)

A rare c.183_187dupCTCAC mutation of the acetylcholine receptor CHRNE gene in a South Asian female with congenital myasthenic syndrome: a case report
by: Chang, T, et al.
Published: (2016)

Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.
by: Belaya, K, et al.
Published: (2012)

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
by: Cossins, J, et al.
Published: (2013)